The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Minimal residual disease (MRD) negativity (neg) in patients (pts) with relapsed or refractory multiple myeloma (RRMM) treated with belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide, bortezomib, and dexamethasone (PVd): Analysis from the DREAMM-8 trial.
 
Suzanne Trudel
Honoraria - Amgen; Forus; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - BMSi; GlaxoSmithKline; Roche
Research Funding - Amgen; BMSi; Genentech; GlaxoSmithKline; Janssen; K36 therapeutics; Pfizer; Roche
 
Meral Beksac
Consulting or Advisory Role - BMS Turkey (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Oncopeptides (Inst); Pfizer (Inst); Sanofi (Inst); Takeda (Inst)
Speakers' Bureau - BMS Turkey (Inst); Menarini (Inst); Sanofi (Inst); Takeda (Inst)
 
Ludek Pour
No Relationships to Disclose
 
Sosana Delimpasi
Honoraria - Amgen; GlaxoSmithKline; Janssen; Takeda
 
Vladimir Vorobyev
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Janssen Oncology; Novartis; Roche; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; BeiGene; BioCad; BMSi; Janssen; MSD; Novartis; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Hang Quach
Consulting or Advisory Role - Antengene (Inst); Bristol-Myers Squibb/Celgene; GlaxoSmithKline (Inst); Janssen-Cilag; Karyopharm Therapeutics (Inst); Pfizer; Roche; Sanofi (Inst)
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Kihyun Kim
Consulting or Advisory Role - Abbvie; BMSi; GlaxoSmithKline; Johnson & Johnson
Research Funding - BMSi; Johnson & Johnson; Sanofi
 
Kazuhito Suzuki
Honoraria - Bristol-Myers Squibb; Janssen; Sanofi
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda
 
Jie Ma
Employment - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Yinjiao Ma
Employment - GlaxoSmithKline
 
Ianire Garrobo-Calleja
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Giulia Fulci
Employment - GlaxoSmithKline
 
Elisabet Manasanch
Employment - GlaxoSmithKline
 
Neal Sule
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Brandon Kremer
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Pralay Mukhopadhyay
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Joanna Opalinska
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Blenrep related patents
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda